{"name":"Venthera, Inc., a BridgeBio company","slug":"venthera-inc-a-bridgebio-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPOXRvV1hidXh1OWZxemh0UUxCZVhWUUd2VlBwX2FBSUpsZDhoNGVWalMzb3hMM3hKNjRHQzRJeXF6ZDFFcy1WTWU2YkpvSUk2TlBXaGRDSHJwU2JWU1ZnZUlMbjZrOVNpZE9rbkdKeDVtU3FwSmlkZDltRU9FQVJXS0NaRkFHSXNrNF9nd2s1VmFEZzFSUmFoZi1OZ3NlMHNNWEE?oc=5","date":"2021-05-24","type":"trial","source":"UW–Madison News","summary":"Clinical trial repurposes cancer drug for treatment of vascular malformations - UW–Madison News","headline":"Clinical trial repurposes cancer drug for treatment of vascular malformations - UW–Madison News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}